Apologies Longreach, I don't mean to come across as a downramper.
My point is about the performance rights being issued. "Show me the incentives, and I'll show you the outcome" someone much smarter than me once quipped (Charlie Munger).
I agree with your comments that the company clearly needed a turnaround, and new management seem to be doing it. But, the incentives they have is increasing top line adjusted EBITDA - not the EPS you reference. If EPS was their incentives, I doubt they would be as aggressive on the acquisitions, nor as aggressive on the shareholder dilution. I would be happy to pay management a huge compensation if they are providing me - the shareholder - with excess returns. But to my mind, the management's performance rights are not structured that way. If was a shareholder, I'd be keeping a very close eye on what the next round of performance incentives are.
- Forums
- ASX - By Stock
- Ann: EGL Trading Update
Apologies Longreach, I don't mean to come across as a...
Featured News
Add EGL (ASX) to my watchlist
(20min delay)
|
|||||
Last
32.0¢ |
Change
-0.030(8.57%) |
Mkt cap ! $121.7M |
Open | High | Low | Value | Volume |
34.0¢ | 35.0¢ | 32.0¢ | $216.7K | 656.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 84000 | 31.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.0¢ | 315125 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 84000 | 0.315 |
4 | 18628 | 0.310 |
1 | 50000 | 0.305 |
3 | 63323 | 0.300 |
1 | 50000 | 0.290 |
Price($) | Vol. | No. |
---|---|---|
0.320 | 315125 | 4 |
0.325 | 10000 | 1 |
0.335 | 15000 | 1 |
0.340 | 40911 | 2 |
0.345 | 8000 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
EGL (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online